Humacyte Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.46

+0.01 (+1.56%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 9 82%

Hold 2 18%

Sell 0 0%

Price Target

Analyst Price Target +3,243.6% upside

Low Target $10.64

Average Target $15.22

High Target $24.41

Current Price $0.46

Current
$0.46

Target
$15.22

$10.64 $15.22 avg $24.41

Scenario Analysis

Bear Case

$10.64

2,237.4%

Low target

Base Case

$15.22

+3,243.6%

Avg target

Bull Case

$24.41

+5,262.5%

High target

Risk/Reward

2.4x

Favorable

Price in Context

52-Week High

$1.53

-70.2% from high

52-Week Low

$0.34

+35.1% from low

Target vs 52W High

$15.22

+898.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	38	82%	$257.58	-12.5%
AMGN Amgen Inc	Hold	42	43%	$190.87	-59.0%
GILD Gilead Sciences Inc	Strong Buy	36	83%	$362.68	+115.4%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	82%	$438.34	-18.5%
MRNA Moderna Inc	Hold	31	32%	$149.45	-35.4%
REGN Regeneron Pharmaceuticals	Buy	36	72%	$76.80	-91.9%
NTRA Natera Inc	Strong Buy	31	90%	$142.91	-55.7%
RVMD Revolution Medicines Inc	Strong Buy	31	94%	$114.11	-35.3%